News Medcura Expands its Senior Leadership Team and Appoints Leading Neurosurgeon Dr. Kenneth Renkens as Chief Medical Officer RIVERDALE, Md., April 26, 2022 /PRNewswire/ -- Medcura, Inc., a commercial-stage medical device company, today…Super UserMay 2, 2022
News Life Sciences | Virginia Economic Development Partnership Top companies in the life sciences industry choose to locate in Virginia – and flourish…Super UserMay 2, 2022
News Medcura Expands its Senior Leadership Team and Appoints Leading Neurosurgeon Dr. Kenneth Renkens as Chief Medical Officer · BioBuzz RIVERDALE, Md., April 26, 2022 /PRNewswire/ — Medcura, Inc., a commercial-stage medical device company, today announced the expansion of…Super UserMay 2, 2022
News Emmes and Casimir Announce Research About a Novel, Home-Based Assessment for Duchenne Muscular Dystrophy | Emmes Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public…Super UserMay 2, 2022
News The ARPA-H (Health) Headquarters: Where Will It Be, and Should I Care? The medical science publication Stat just published an article about Congressional interest in the location of…Super UserApril 26, 2022
News Raymond Blanchard, Associate Director of IP & Licensing with QIAGEN, visits BioTalk QIAGEN Associate Director of IP & Licensing, Raymond Blanchard, chats with Rich Bendis on BioTalk…Super UserApril 25, 2022
BioTalk with Rich Bendis Podcast Raymond Blanchard, Associate Director of IP & Licensing with QIAGEN, visits BioTalk QIAGEN Associate Director of IP & Licensing, Raymond Blanchard, chats with Rich Bendis on BioTalk…Super UserApril 25, 2022
News 500,000-square-foot life science campus coming to Jefferson Technology Park Apr. 22—Construction will start this September on a 500,000-square-foot life science campus in Frederick County's…Super UserApril 25, 2022
News AURP to Host 2022 BIO Health Caucus on “Growing Bio Clusters and Bio Companies” June 12-13 in San Diego – Digital Journal TUCSON, AZ / ACCESSWIRE / April 20, 2022 / AURP, the leading non-profit representing research…Super UserApril 25, 2022
News Initial Results from Novavax’ COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine Phase 1/2 clinical trial of COVID-19-Influenza combination vaccine candidate indicates vaccine is well-tolerated and immunogenic…Super UserApril 25, 2022